These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 11561758)

  • 1. Telomerase activity and expression of telomerase reverse transcriptase correlated with cell proliferation in meningiomas and malignant brain tumors in vivo.
    Cabuy E; de Ridder L
    Virchows Arch; 2001 Aug; 439(2):176-84. PubMed ID: 11561758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase activity and expression of the telomerase catalytic subunit, hTERT, in meningioma progression.
    Simon M; Park TW; Leuenroth S; Hans VH; Löning T; Schramm J
    J Neurosurg; 2000 May; 92(5):832-40. PubMed ID: 10794298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations between the expression of hTERT and α and β splice variants in human brain tumors.
    Khajehgoodari R; Khorvash F; Kheirollahi M; Mirsafaie M; Salehi M
    Adv Clin Exp Med; 2019 Apr; 28(4):507-513. PubMed ID: 31044567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between telomerase activity, hTERT and telomere length for intracranial tumours.
    Maes L; Van Neste L; Van Damme K; Kalala JP; De Ridder L; Bekaert S; Cornelissen M
    Oncol Rep; 2007 Dec; 18(6):1571-6. PubMed ID: 17982646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase expression in intracranial tumours: prognostic potential for malignant gliomas and meningiomas.
    Falchetti ML; Pallini R; Larocca LM; Verna R; D'Ambrosio E
    J Clin Pathol; 1999 Mar; 52(3):234-6. PubMed ID: 10450187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase activity and hTERT protein expression in meningiomas: an analysis in vivo versus in vitro.
    Maes L; Kalala JP; Cornelissen R; de Ridder L
    Anticancer Res; 2006; 26(3B):2295-300. PubMed ID: 16821605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase in intracranial meningiomas.
    Boldrini L; Pistolesi S; Gisfredi S; Ursino S; Lupi G; Caniglia M; Pingitore R; Basolo F; Parenti G; Fontanini G
    Int J Mol Med; 2003 Dec; 12(6):943-7. PubMed ID: 14612971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of astrocytomas and meningiomas: an evaluation in vitro.
    Maes L; Kalala JP; Cornelissen M; de Ridder L
    Cell Prolif; 2007 Feb; 40(1):14-23. PubMed ID: 17227292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ detection of telomerase catalytic subunit mRNA in glioblastoma multiforme.
    Falchetti ML; Pallini R; D'Ambrosio E; Pierconti F; Martini M; Cimino-Reale G; Verna R; Maira G; Larocca LM
    Int J Cancer; 2000 Dec; 88(6):895-901. PubMed ID: 11093811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of telomerase status by semiquantitative and in situ assays, and by real-time reverse transcription-polymerase chain reaction (telomerase reverse transcriptase) assay in bladder carcinomas.
    Longchampt E; Lebret T; Molinie V; Bieche I; Botto H; Lidereau R
    BJU Int; 2003 Apr; 91(6):567-72. PubMed ID: 12656916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for telomerase involvement in the angiogenesis of astrocytic tumors: expression of human telomerase reverse transcriptase messenger RNA by vascular endothelial cells.
    Pallini R; Pierconti F; Falchetti ML; D'Arcangelo D; Fernandez E; Maira G; D'Ambrosio E; Larocca LM
    J Neurosurg; 2001 Jun; 94(6):961-71. PubMed ID: 11409526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance.
    Alonso MM; Fueyo J; Shay JW; Aldape KD; Jiang H; Lee OH; Johnson DG; Xu J; Kondo Y; Kanzawa T; Kyo S; Bekele BN; Zhou X; Nigro J; McDonald JM; Yung WK; Gomez-Manzano C
    J Natl Cancer Inst; 2005 Nov; 97(21):1589-600. PubMed ID: 16264179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of INK4a(p16-p14ARF)/INK4b(p15) expression and telomerase activation in meningioma progression.
    Simon M; Park TW; Köster G; Mahlberg R; Hackenbroch M; Boström J; Löning T; Schramm J
    J Neurooncol; 2001 Dec; 55(3):149-58. PubMed ID: 11859969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Full-length telomerase reverse transcriptase messenger RNA is an independent prognostic factor in neuroblastoma.
    Krams M; Hero B; Berthold F; Parwaresch R; Harms D; Rudolph P
    Am J Pathol; 2003 Mar; 162(3):1019-26. PubMed ID: 12598334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implication of telomerase activity and alternations of telomere length in the histologic characteristics of intracranial meningiomas.
    Chen HJ; Liang CL; Lu K; Lin JW; Cho CL
    Cancer; 2000 Nov; 89(10):2092-8. PubMed ID: 11066050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative expression of human telomerase catalytic subunit (hTERT) transcripts in astrocytic gliomas.
    Kotoula V; Barbanis S; Nikolakaki E; Koufoyannis D; Papadimitriou CS; Karkavelas G
    Acta Neuropathol; 2004 May; 107(5):443-51. PubMed ID: 14986029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma.
    Elder EE; Xu D; Höög A; Enberg U; Hou M; Pisa P; Gruber A; Larsson C; Bäckdahl M
    Mod Pathol; 2003 Mar; 16(3):246-55. PubMed ID: 12640105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PCNA, Ki-67 and hTERT in residual benign meningiomas.
    Maes L; Kalala JP; Cornelissen M; De Ridder L
    In Vivo; 2006; 20(2):271-5. PubMed ID: 16634530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues.
    Kyo S; Kanaya T; Takakura M; Tanaka M; Inoue M
    Int J Cancer; 1999 Jan; 80(1):60-3. PubMed ID: 9935231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of telomerase genes in thyroid carcinoma.
    Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H
    Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.